
VentriPoint Diagnostics Investor Relations Material
Latest events

AGM 2024
VentriPoint Diagnostics

Q1 2025
29 May, 2025

Q4 2024
29 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from VentriPoint Diagnostics Ltd
Access all reports
VentriPoint Diagnostics Ltd. is a Canadian medical device company specializing in the development and commercialization of innovative cardiac diagnostic tools. Their flagship product, the VentriPoint Medical System (VMS+), represents a significant advancement in heart imaging technology. VMS+ is designed to provide a detailed 3D visualization of the heart's structure and function without the need for magnetic resonance imaging (MRI). This system enhances ultrasound capabilities, offering a cost-effective, fast, and accurate diagnostic solution that enables the analysis of all four heart chambers, with a particular focus on the right ventricle, which is challenging to image using conventional methods. The technology's proprietary Knowledge Based Reconstruction (KBR) technology facilitates the creation of 3D heart models and calculates volumes and ejection fractions with accuracy comparable to MRI standards. The company is headquartered in Toronto, Canada, and its shares are listed on the TSX.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
VPT
Country
🇨🇦 Canada